NEW YORK (Thomson Financial) - Signalife Inc. Friday said it had established
a division focused on acquiring and testing therapies that treat cardiovascular
disease at an early stage.
The unit will be called Signalcare, and the company will consider placing it
into a wholly-owned subsidiary.
Shares of Signallife, a Los Angeles-based health care company, closed
Thursday at 76 cents.
Ryan Vlastelica
rv/pc
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|